RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 42 filers reported holding RAIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $11,703,001 | +14.3% | 1,336,722 | +4.1% | 0.01% | +14.3% |
Q4 2022 | $10,242,378 | +162.6% | 1,283,506 | -20.7% | 0.01% | +133.3% |
Q3 2022 | $3,899,896 | -4.4% | 1,618,208 | +120.9% | 0.00% | 0.0% |
Q2 2022 | $4,080,000 | +26.6% | 732,655 | +15.1% | 0.00% | +50.0% |
Q1 2022 | $3,223,000 | -79.7% | 636,768 | -48.2% | 0.00% | -71.4% |
Q4 2021 | $15,841,000 | -22.6% | 1,230,455 | -12.2% | 0.01% | -22.2% |
Q3 2021 | $20,455,000 | -4.8% | 1,402,074 | -3.5% | 0.01% | 0.0% |
Q2 2021 | $21,491,000 | – | 1,452,615 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,571,379 | $7,967,000 | 2.01% |
Cormorant Asset Management, LP | 2,326,660 | $11,796,000 | 0.91% |
BVF INC/IL | 3,526,729 | $17,881,000 | 0.72% |
Boxer Capital, LLC | 1,175,000 | $5,957,000 | 0.31% |
Perceptive Advisors | 2,483,619 | $12,592,000 | 0.25% |
Logos Global Management LP | 134,194 | $680,000 | 0.09% |
Lumina Fund Management LLC | 6,000 | $30,000 | 0.01% |
Woodline Partners LP | 119,700 | $607,000 | 0.01% |
Trexquant Investment LP | 28,373 | $144,000 | 0.01% |
Alyeska Investment Group, L.P. | 125,000 | $634,000 | 0.01% |